Human Vaccine

Human Vaccine LLC is a Moscow-based pharmaceutical company and a wholly owned subsidiary of the Russian Direct Investment Fund (RDIF). Established in September 2020, the company serves as the primary commercial and licensing vehicle for the global distribution, technology transfer, and supply of the Sputnik V and Sputnik Light COVID-19 vaccines. Human Vaccine LLC manages international supply agreements, coordinates with contract development and manufacturing organizations (CDMOs) globally, and partners with international organizations like UNICEF to facilitate vaccine access. The company's portfolio is centered on adenoviral vector vaccine technologies developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.